Recommend Human Vaccines to your librarian for 2008. Download form here.

Sign up for TOC Alerts

home subscribe search archive forthcoming

Email this page Print this page

Research Paper

Seroprevalence of anti Vi antibodies and immunogenicity of Typhim Vi vaccine in children

Divya Gupta, M.M.A. Faridi , Anju Aggarwal and Iqbal Kaur

volume 4 | issue 4

july/august 2008
Pages: 305 - 308

Purchase article for $19

Subscribe to this journal for $79/year

This prospective study was carried out on 250 children between 6 months to 5 years of age to determine seroprevalence of anti Vi antibodies and to measure seroresponse and percent seroconversion to TyphimVi polysaccharide vaccine in children 2-5 years of age. Fifty children each were enrolled between 6 to12 months of age (Group A), between 1- 2 years of age(Group B), between 2-3 years of age(Group C), between 3-4 years of age (Group D) and between 4-5 years of age (Group E). Anti- Vi antibody baseline titres were determined in all children. Children in Groups C to E were vaccinated with Typhim Vi vaccine. Baseline and postvaccination antibody titres were determined by ELISA. Test serum which had antibody levels >1 µg/ml were scored as seropositive. Of 250 children, 3 had base line anti-Vi antibodies >1µg/ml. Following immunization overall seroconversion rate was 77.5% with 65.3%, 78.2% and 88% children showing seroconversion in Groups C, D and E respectively. Seroconversion was significantly more in Group E children compared to Group C (p=0.0148). There were no significant adverse reactions following vaccination. The study highlights very low prevalence of baseline anti Vi antibodies in children between 6 months and less than 5 years of age and shows high immunogenicity and safety of Typhim Vi polysaccharide vaccine in children 2- 5 years of age.

Authors

Divya Gupta

Department of Pediatrics; University College of Medical Sciences; Delhi, India

M.M.A. Faridi

Department of Pediatrics; University College of Medical Sciences; Delhi, India

Anju Aggarwal

Department of Pediatrics; University College of Medical Sciences; Delhi, India

Iqbal Kaur

Department of Pediatrics; University College of Medical Sciences; Delhi, India


Purchase article for $19

Subscribe to this journal for $79/year